Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin PK Interaction with Ketoconazole
NCT01267084Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2011
- Primary completion
- Nov 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in solid tumor, sponsored by Janssen Pharmaceutical. Started Feb 2011; status: completed.
02
Drugs
trabectedin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01267084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01267084.